MedGenome unveils MetaSeq, a groundbreaking blood test capable of detecting over 1,400 pathogens in just five days, enhancing ...
Every year, millions of newborns undergo routine screening as a preventive strategy to detect inherited disorders before symptoms emerge.
The global HLA typing market is expected to expand at a compound annual growth rate (CAGR) of approximately 6% during the ...
Quest Diagnostics debuts a new blood test for myeloma MRD, offering NGS-level sensitivity and a less invasive alternative to ...
Medical Device Network on MSN
Quest launches flow cytometry MRD test for myeloma
Quest expects the new blood test will support response monitoring in clinical trials.
Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced the launch of a novel ...
The Rwanda Forensic Institute (RFI) is in the final stages of preparations to introduce prenatal DNA testing for unborn ...
Global navigation satellite systems (GNSS) are vital for positioning autonomous vehicles, buses, drones, and outdoor robots. Yet its accuracy often degrades in dense urban areas due to signal blockage ...
Opportunities in the Global Refractory Follicular Lymphoma Diagnostics Market include the growing need for MRD monitoring and liquid biopsies, driven by the rise in hematologic malignancies. The surge ...
Automated Twist NGS library preparation workflows available on SPT Labtech’s firefly platform via the firefly cloud ...
Ongoing combination of Twist NGS library preparation kits with firefly will continue to expand SPT Labtech’s portfolio of ...
News-Medical.Net on MSN
Novel liquid biopsy technology could advance cancer diagnostics and monitoring
A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing challenge of simultaneously achieving high sensitivity, broad coverage, and simple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results